Avidity Historical Cash Flow
| RNA Stock | USD 43.33 0.47 1.07% |
Analysis of Avidity Biosciences cash flow over time is an excellent tool to project Avidity Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Investing Activities of 197.6 K or Sale Purchase Of Stock of 485.1 K as it is a great indicator of Avidity Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Avidity Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Avidity Biosciences is a good buy for the upcoming year.
Avidity |
About Avidity Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Avidity balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Avidity's non-liquid assets can be easily converted into cash.
Avidity Biosciences Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Avidity Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Avidity Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Depreciation
Depreciation indicates how much of Avidity Biosciences value has been used up. For tax purposes Avidity Biosciences can deduct the cost of the tangible assets it purchases as business expenses. However, Avidity Biosciences must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most accounts from Avidity Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Avidity Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.At present, Avidity Biosciences' Capital Expenditures is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Financing Activities is expected to grow to about 135.1 M, whereas Sale Purchase Of Stock is forecasted to decline to about 485.1 K.
| 2023 | 2024 (projected) | Change To Account Receivables | 627.3K | 557.6K | Capital Expenditures | 4.2M | 4.4M |
Avidity Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Avidity Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Avidity Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 235K | 1.1M | 3.7M | 2.8M | 4.2M | 4.4M | |
| Total Cash From Financing Activities | 89.2M | 272.0M | 176.3M | 346.2M | 93.9M | 135.1M | |
| End Period Cash Flow | 94.6M | 321.7M | 320.7M | 340.6M | 185.4M | 200.2M | |
| Investments | (235K) | (6.7M) | (78.8M) | (190.0M) | (188.9M) | (179.4M) | |
| Change In Cash | 91.5M | 227.1M | (1.0M) | 19.9M | (155.3M) | (147.5M) | |
| Stock Based Compensation | 406K | 4.3M | 17.1M | 27.1M | 38.2M | 40.1M | |
| Free Cash Flow | 2.3M | (38.2M) | (98.6M) | (139.1M) | (123.3M) | (117.1M) | |
| Change In Working Capital | 19.1M | 2.3M | 5.3M | 9.8M | 61.1M | 64.2M | |
| Begin Period Cash Flow | 3.1M | 94.6M | 321.7M | 320.7M | 340.6M | 199.5M | |
| Total Cashflows From Investing Activities | (235K) | (7.8M) | (82.5M) | (190.0M) | (171.0M) | (162.4M) | |
| Other Cashflows From Financing Activities | 92.1M | (21.4M) | 1.6M | 1.4M | 33.3M | 35.0M | |
| Depreciation | 348K | 373K | 639K | 1.4M | 2.1M | 2.2M | |
| Other Non Cash Items | 7.3M | 139K | 163K | (615K) | (8.3M) | (7.9M) | |
| Total Cash From Operating Activities | 2.5M | (37.1M) | (94.8M) | (136.3M) | (119.1M) | (113.1M) | |
| Change To Operating Activities | (19K) | (317K) | 3.7M | (3.4M) | (3.0M) | (2.9M) | |
| Issuance Of Capital Stock | 72.7M | 300.3M | 185.9M | 344.8M | 303.6M | 221.3M | |
| Net Income | (24.7M) | (44.4M) | (118.0M) | (174.0M) | (212.2M) | (201.6M) | |
| Change To Netincome | 7.4M | 4.5M | 17.2M | 26.5M | 30.5M | 32.0M | |
| Change To Liabilities | 19.4M | 2.6M | 1.6M | 13.2M | 15.2M | 8.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.88) | Revenue Per Share 0.103 | Quarterly Revenue Growth (0.17) | Return On Assets (0.18) | Return On Equity (0.28) |
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.